These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27779715)

  • 1. miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7.
    Zhao W; Zhang X; Liu J; Sun B; Tang H; Zhang H
    Oncol Rep; 2016 Dec; 36(6):3691-3699. PubMed ID: 27779715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis.
    Zhou S; Huang Q; Zheng S; Lin K; You J; Zhang X
    Tumour Biol; 2016 May; 37(5):6837-45. PubMed ID: 26662313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liraglutide inhibits the proliferation and promotes the apoptosis of MCF-7 human breast cancer cells through downregulation of microRNA-27a expression.
    Zhao W; Zhang X; Zhou Z; Sun B; Gu W; Liu J; Zhang H
    Mol Med Rep; 2018 Apr; 17(4):5202-5212. PubMed ID: 29393459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α.
    Ali HO; Arroyo AB; González-Conejero R; Stavik B; Iversen N; Sandset PM; Martínez C; Skretting G
    J Thromb Haemost; 2016 Jun; 14(6):1226-37. PubMed ID: 26999003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.
    Moazzeni H; Najafi A; Khani M
    Mol Cell Probes; 2017 Aug; 34():45-52. PubMed ID: 28546132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells.
    Zhang S; Ma C; Pang H; Zeng F; Cheng L; Fang B; Ma J; Shi Y; Hong H; Chen J; Wang Z; Xia J
    Biochem Biophys Res Commun; 2016 Jan; 469(1):55-61. PubMed ID: 26592661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
    Sun FD; Wang PC; Luan RL; Zou SH; Du X
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid raft-mediated miR-3908 inhibition of migration of breast cancer cell line MCF-7 by regulating the interactions between AdipoR1 and Flotillin-1.
    Li Y; Shan F; Chen J
    World J Surg Oncol; 2017 Mar; 15(1):69. PubMed ID: 28327197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
    Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
    Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
    Sharma P; Kumar S
    Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin.
    Chen W; Qi J; Bao G; Wang T; Du CW; Wang MD
    Mol Med Rep; 2015 Jul; 12(1):1515-23. PubMed ID: 25777779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of miR-449a on proliferation and migration of human breast cancer cell line MCF-7].
    Wang HL; Xiao Y; Wu L; Ma DC
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jun; 33(6):508-513. PubMed ID: 29931899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression.
    Zhang H; Fan Q
    Oncol Rep; 2015 Oct; 34(4):2163-70. PubMed ID: 26239614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27.
    Ren YQ; Fu F; Han J
    Med Sci Monit; 2015 May; 21():1297-303. PubMed ID: 25943633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression.
    Xia H; Long J; Zhang R; Yang X; Ma Z
    Biomed Pharmacother; 2015 Oct; 75():105-10. PubMed ID: 26276160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.